Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals

BACKGROUND: Newly diagnosed HIV-positive individuals are 35 to 100-fold more susceptible to Streptococcus pneumoniae infection compared to non-infected individuals. Therefore, the 23-valent pneumococcal polysaccharide vaccine (PPV23) has previously been recommended, though efficacy and effectiveness...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J AIDS Clin Res
Huvudupphovsmän: Leggat, David J, Iyer, Anita S, Ohtola, Jennifer A, Kommoori, Sneha, Duggan, Joan M, Georgescu, Claudiu A, Khuder, Sadik A, Khaskhely, Noor M, Westerink, MA Julie
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405239/
https://ncbi.nlm.nih.gov/pubmed/25908995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-6113.1000419
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk